Assetmark »

Citius Pharmaceuticals shares owned by Assetmark

Quarter-by-quarter ownership of Citius Pharmaceuticals (CTXR) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Citius Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Citius Pharmaceuticals held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Pharmaceuticals by Assetmark

Quarter filed Position value Share count Share price at filing
2026-03-31 $334 372 0.90

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Series Trust State Street Spd (JNK)
Ishares Tr Iboxx Hi Yd Etf (HYG)

View all positions for Assetmark

Top funds holding Citius Pharmaceuticals

Heights Capital Management
Geode Capital Management
Vanguard Group
Vanguard Capital Management
XTX Topco
Susquehanna International
Vanguard Fiduciary Trust
BlackRock
Hrt Financial
Asset Advisory Group
UBS Group
Jane Street
Northern Trust
Citadel Advisors
LPL Financial

View all funds holding Citius Pharmaceuticals